Clinical trial
A Randomized Phase II Trial of Preoperative Chemoradiation (Preop CRT) Followed by CapOx (Capecitabine Plus Oxaliplatin) Versus Preop CRT Alone for Locally Advanced Rectal Cancer (LARC)
NCT01952951 is registered in ClinicalTrials.gov with National Cancer Center, Korea as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Phase II Trial of Preoperative Chemoradiation (Preop CRT) Followed by CapOx (Capecitabine Plus Oxaliplatin) Versus Preop CRT Alone for Locally Advanced Rectal Cancer (LARC)
- Lead sponsor
- National Cancer Center, Korea
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- June 30, 2014
- Completion date
- December 31, 2019
- Enrollment
- 110 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.